6.35BUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
KYG0519B1023
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.48
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.17
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
903,028,992
Gross Profit TTM
875,580,992
EBITDA
-263,087,008
Profit Margin
-39.90%
Return On Assets TTM
-7.14%
Return On Equity TTM
-52.38%
Revenue Per Share TTM
3.104
Qtly Revenue Growth YOY
477.30%
Diluted Eps TTM
-0.17
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
7.0345
Price Book MRQ
60.5839
Enterprise Value Revenue
13
Enterprise Value EBITDA
0
325.00
3.76%79.31
2.44%198.09
2.19%449.99
1.45%150.52
1.32%96.50
1.05%268.11
0.60%523.17
0.23%569.19
-2.96%565.11
-0.53%